Please do not leave this page until complete. This can take a few moments.
Pharmacy giant CVS will pay more than $12 million to MassHealth after the attorney general alleged the company charged higher prices to the Medicaid program than to cash-paying customers in the general public.
Attorney General Andrea Campbell on Wednesday announced a settlement agreement with CVS in which the company will pay $12.25 million to the program, and implement a "yearly reconciliation process" to ensure it does not overcharge MassHealth in the future.
Campbell and her counterparts in Connecticut, Indiana and Oklahoma jointly filed a civil action in May, alleging that CVS customers who paid in cash through the ScriptSave program received discounts for years that were not offered to Medicaid recipients.
In a statement, Campbell said the settlement would "prevent future inaccurate price reporting and ensure MassHealth has the resources it needs to continue serving Massachusetts residents."
"When pharmacies overcharge MassHealth, they're undermining the integrity of our public programs and leaving taxpayers to foot the bill," she said.
A CVS spokesperson said the company agreed to the settlement "to avoid the time and expense of further litigation with Massachusetts," adding that it does not represent "an admission of liability or wrongdoing."
"The settled claims involve only Massachusetts Medicaid's unique most favored nations ('MFN') regulation," spokesperson Kara Page, said. "We'll continue vigorously defending against the claims concerning CVS Pharmacy's usual and customary [U&C] pricing brought by remaining plaintiffs in the case. For the last several years, many pharmacies, including CVS Pharmacy, have been named as defendants in other U&C lawsuits accusing the pharmacies of having submitted inflated U&C prices. In the cases involving CVS, we've prevailed many times, including by court dismissal, jury verdict, and arbitrator award."
Stay connected! Every business day, WBJ Daily Report will be delivered to your inbox by noon. It provides a daily update of the area’s most important business news.
Sign upWorcester Business Journal provides the top coverage of news, trends, data, politics and personalities of the Central Mass business community. Get the news and information you need from the award-winning writers at WBJ. Don’t miss out - subscribe today.
SubscribeWorcester Business Journal presents a special commemorative edition celebrating the 300th anniversary of the city of Worcester. This landmark publication covers the city and region’s rich history of growth and innovation.
See Digital EditionStay connected! Every business day, WBJ Daily Report will be delivered to your inbox by noon. It provides a daily update of the area’s most important business news.
Worcester Business Journal provides the top coverage of news, trends, data, politics and personalities of the Central Mass business community. Get the news and information you need from the award-winning writers at WBJ. Don’t miss out - subscribe today.
Worcester Business Journal presents a special commemorative edition celebrating the 300th anniversary of the city of Worcester. This landmark publication covers the city and region’s rich history of growth and innovation.
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
This website uses cookies to ensure you get the best experience on our website. Our privacy policy
To ensure the best experience on our website, articles cannot be read without allowing cookies. Please allow cookies to continue reading. Our privacy policy
0 Comments